Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Expands MS Pharma's geographic footprint, and complements its existing chronic disease portfolio
April 16, 2019
By: Kristin Brooks
Managing Editor, Contract Pharma
MS Pharma, based in Jordan and operating across the Middle East, Turkey and Africa, has entered into an agreement to acquire Genepharm, a European pharmaceutical company. Genepharm’s senior management will remain to help guide the company through the next phase of its growth. The transaction is expected to close in April. Based in Greece, Genepharm develops, manufactures and out-licenses high-value generic pharmaceutical products and has an extensive network of 223 customers across 70 countries. Genepharm combines strong R&D capabilities with manufacturing capacity in conventional solids, sterile liquid (oncology) and oncology oral solids. The acquisition expands MS Pharma’s geographic footprint, and complements its existing chronic disease portfolio with the addition of several important products in cardiovascular, CNS and oncology. The acquisition will allow Genepharm to access MS Pharma’s manufacturing facilities and product portfolio and be part of a group with more than 2,000 employees. Genepharm’s portfolio will be strengthened with sterile injectable products and biotechnology candidates and plans are in place to significantly increase the development resources in Athens. Ghiath Sukhtian, chairman of MS Pharma said, “This acquisition is highly complementary and synergistic to our business, and marks an important milestone in our growth plans. Genepharm’s management team has built a successful business, and we look forward to supporting them in growing the Genepharm business. We believe this acquisition will enable Genepharm to offer a wider range of products and technologies to its customers in Europe and around the world.” Genepharm said, “We are excited to be entering into a new phase of growth with MS Pharma. This acquisition will help accelerate Genepharm’s growth plans and will enable the company to offer a wider range of products to its partners and customers.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !